IRLAB Therapeutics AB
STO:IRLAB A

Watchlist Manager
IRLAB Therapeutics AB Logo
IRLAB Therapeutics AB
STO:IRLAB A
Watchlist
Price: 12.6 SEK -1.95%
Market Cap: 652.5m SEK
Have any thoughts about
IRLAB Therapeutics AB?
Write Note

IRLAB Therapeutics AB
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

IRLAB Therapeutics AB
PP&E Net Peer Comparison

Comparables:
CALTX
CAMX
S
SECARE
MOB
I
FLERIE

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
IRLAB Therapeutics AB
STO:IRLAB A
PP&E Net
kr6.7m
CAGR 3-Years
16%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Calliditas Therapeutics AB
STO:CALTX
PP&E Net
kr59.4m
CAGR 3-Years
89%
CAGR 5-Years
52%
CAGR 10-Years
N/A
Camurus AB
STO:CAMX
PP&E Net
kr37.5m
CAGR 3-Years
6%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
S
Swedencare AB (publ)
STO:SECARE
PP&E Net
kr522.4m
CAGR 3-Years
118%
CAGR 5-Years
100%
CAGR 10-Years
N/A
Moberg Pharma AB (publ)
STO:MOB
PP&E Net
kr4.9m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
InDex Pharmaceuticals Holding AB
STO:FLERIE
PP&E Net
kr1.3m
CAGR 3-Years
-22%
CAGR 5-Years
7%
CAGR 10-Years
N/A

See Also

What is IRLAB Therapeutics AB's PP&E Net?
PP&E Net
6.7m SEK

Based on the financial report for Dec 31, 2023, IRLAB Therapeutics AB's PP&E Net amounts to 6.7m SEK.

What is IRLAB Therapeutics AB's PP&E Net growth rate?
PP&E Net CAGR 5Y
41%

Over the last year, the PP&E Net growth was -17%. The average annual PP&E Net growth rates for IRLAB Therapeutics AB have been 16% over the past three years , 41% over the past five years .

Back to Top